Company / EPS (Basic)
Haemonetics EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$2.27
FY2025
5-year range
$0.85 / $2.32
FY2021-FY2025
Trend
+167.1%
vs FY2024
Sector context
#53 of 160
Health Care
What the data says
At $2.27, Haemonetics's eps (basic) ranks #53 of 160 in the Health Care sector. EPS (Basic) has fluctuated over the past 10 years, ranging from $-1.09 in FY2018 to $2.32 in FY2023.
Based on SEC 10-K filings.
2.27 in FY2025 with a 5-year CAGR of +7.7%.
Declined from $2.32 to $2.27 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +7.7%
- 10-Year CAGR
- -
Sector benchmark
#53 of 160 in Health CareTop 33% of 160This company $2.27 Sector average $1.67
▼
+35.7% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 167.1% year-over-year.
- Ranks #53 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2023.
- Lowest eps (basic) in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.27 | +167.1% |
| FY2024 | $0.85 | -63.4% |
| FY2023 | $2.32 | +2.2% |
| FY2022 | $2.27 | +167.1% |
| FY2021 | $0.85 | -45.9% |
| FY2020 | $1.57 | +4.0% |
| FY2019 | $1.51 | +238.5% |
| FY2018 | -$1.09 | -430.3% |
| FY2017 | $0.33 | -51.5% |
| FY2016 | $0.68 | -10.5% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026